Oncology & Cancer

Studying the development of ovarian cancer with organoids

High-grade serous ovarian cancer is the most common type of ovarian cancer, and has the lowest rate of survival. It is often only diagnosed when it has already spread within the pelvis and abdomen, making it harder to treat. ...

Oncology & Cancer

New type of immunotherapy hinders the spread of ovarian cancer

Malignant ovarian cancer is insidious: Known and feared for vague and uncharacteristic symptoms that often mean the disease is discovered so late that on average only four out of six patients are still alive after five years. ...

Oncology & Cancer

Managing ovarian cancer risk in women with BRCA1/2 genetic variants

BRCA1 and BRCA2 genetic variants are a clinically important risk factor for the development of ovarian and breast cancer, and women who carry these variants have a lifetime risk of ovarian cancer of 39%-44% and 11%-17%, respectively.

Oncology & Cancer

Researchers make next move in the fight against ovarian cancer

Ovarian cancer claims the highest mortality rate of all gynecologic cancers, as high as 70 percent—in part because the disease is rarely detected earlier than stage 3 or 4. When the disease is discovered early in its development, ...

page 1 from 9